World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
139
Citations
75032
World Ranking
1752
National Ranking
1001

Overview

David L. Rimm is affiliated with Yale University in the United States and specializes primarily in Medicine, with a significant body of work in Biochemistry, Genetics and Molecular Biology.

Their research spans various subfields including Oncology, Cancer Research, Immunology, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

Main topics covered in their work are:

  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Immunotherapy and Immune Responses
  • Radiomics and Machine Learning in Medical Imaging
  • HER2/EGFR in Cancer Research
  • Cancer Cells and Metastasis
  • Monoclonal and Polyclonal Antibodies Research

Among the recent papers authored or coauthored by David L. Rimm are:

  • "PD-L1 as a biomarker of response to immune-checkpoint inhibitors," 2021, Nature Reviews Clinical Oncology
  • "Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update," 2020, Journal of Clinical Oncology
  • "Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group," 2020, JNCI Journal of the National Cancer Institute
  • "Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update," 2020, Archives of Pathology & Laboratory Medicine
  • "Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue," 2022, JAMA Oncology

Frequent collaborators in their research include:

  • Thazin Nwe Aung
  • Myrto Moutafi
  • Lajos Pusztai
  • Niki Gavrielatou
  • Aileen I. Fernandez

David L. Rimm has published extensively in several scientific journals, with the highest number of publications in:

  • Cancer Research
  • Clinical Cancer Research
  • Modern Pathology
  • Journal of Clinical Oncology
  • Journal for ImmunoTherapy of Cancer

Best Publications

  • X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

    Robert L. Camp;Marisa Dolled-Filhart;David L. Rimm

  • The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    R. Salgado;C. Denkert;S. Demaria;N. Sirtaine

  • Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

    Levi A. Garraway;Hans R. Widlund;Mark A. Rubin;Gad Getz

  • Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

    Chad J. Creighton;Xiaoxian Li;Melissa Landis;J. Michael Dixon

  • Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology

    Kaustav Bera;Kurt A. Schalper;David L. Rimm;Vamsidhar Velcheti

  • Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin.

    Karyn L. Cepek;Sunil K. Shaw;Sunil K. Shaw;Christina M. Parker;Gary J. Russell

  • PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    Deborah Blythe Doroshow;Sheena Bhalla;Mary Beth Beasley;Lynette M. Sholl

  • Validation of tissue microarray technology in breast carcinoma.

    Robert L Camp;Lori A Charette;David L Rimm

  • Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex

    David L. Rimm;Erika R. Koslov;Partow Kebriaei;Carol D. Cianci

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.

    Kimberly H. Allison;M. Elizabeth H. Hammond;Mitchell Dowsett;Shannon E. McKernin

  • Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis

    Paul M. Weinberger;Ziwei Yu;Bruce G. Haffty;Diane Kowalski

  • Automated subcellular localization and quantification of protein expression in tissue microarrays.

    Robert L Camp;Gina G Chung;David L Rimm

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Programmed death ligand-1 expression in non-small cell lung cancer.

    Vamsidhar Velcheti;Kurt A Schalper;Daniel E Carvajal;Valsamo K Anagnostou

  • Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.

    Joseph McLaughlin;Gang Han;Kurt A. Schalper;Daniel Carvajal-Hausdorf

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer

    David L. Rimm;Gang Han;Janis M. Taube;Eunhee S. Yi

  • Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

    Scott Gettinger;Jungmin Choi;Katherine Hastings;Anna Truini

  • Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study

    Xiaohong R. Yang;Mark E. Sherman;David L. Rimm;Jolanta Lissowska

  • Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.

    Keith S Hoek;David L Rimm;Kenneth R Williams;Hongyu Zhao

Frequent Co-Authors

Kurt A. Schalper
Kurt A. Schalper Yale University
Harriet M. Kluger
Harriet M. Kluger Yale University
Roy S. Herbst
Roy S. Herbst Yale University
Lajos Pusztai
Lajos Pusztai Yale University
Sherene Loi
Sherene Loi Peter MacCallum Cancer Centre
Roberto Salgado
Roberto Salgado Peter MacCallum Cancer Centre
Bruce G. Haffty
Bruce G. Haffty Rutgers, The State University of New Jersey
Carsten Denkert
Carsten Denkert Philipp University of Marburg
Yuval Kluger
Yuval Kluger Yale University
Scott N. Gettinger
Scott N. Gettinger Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a medical career but want alternative or complementary pathways, several online degree options can set you on a fulfilling journey in healthcare. Programs like a healthcare administration associate degree online are ideal if you want to develop management skills and enter the business side of healthcare quickly.

Nursing professionals can advance their education through asn to np programs, offering a streamlined bridge from an associate degree to a master’s as a nurse practitioner. For those interested in the preventative and nutrition side of medicine, earning an online bs in nutrition enables you to help others build healthier habits.

Aspiring leaders may consider pursuing one of the top cahme-accredited mha programs. These online master’s degrees equip graduates to oversee hospitals, clinics, and healthcare systems. Each of these pathways provides flexibility, diverse career options, and the ability to impact the future of health—often without putting medical school on hold.

Best Scientists Citing David L. Rimm

Trending Scientists

Recently Published Articles